Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanqiao Ren

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Technology in Cancer Research & Treatment|October 19, 2022
Addition of Camrelizumab to Transarterial Chemoembolization in Hepatocellular Carcinoma With Untreatable ProgressionYanqiao Ren, Ziyi Liu, Joyman Makamure, et al.
Journal of Oncology|November 29, 2021
The Efficacy of Radiotherapy in the Treatment of Hepatocellular Carcinoma with Distant Organ MetastasisLei Chen, Zhiwen Wang, Songlin Song, et al.
Frontiers in Oncology|June 3, 2022
The Efficacy and Safety of Transarterial Chemoembolization Plus Iodine 125 Seed Implantation in the Treatment of Hepatocellular Carcinoma With Oligometastases: A Case Series ReportsWeihua Zhang, Linxia Wu, Lei Chen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 6, 2019
Endovascular management of transplant renal artery stenosis: A single-center retrospective studyYanqiao Ren, Fu Xiong, Xuefeng Kan, et al.
European Journal of Medical Research|July 5, 2023
Association of the pretreatment lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced hepatocellular carcinomaTao Sun, Yusheng Guo, Bo Sun, et al.
BMC Gastroenterology|July 1, 2020
Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinomaLei Chen, Xuefeng Kan, Tao Sun, et al.
Scientific Reports|January 10, 2024
Ablation alone is noninferior to radiotherapy plus ablation in the patients with early-stage hepatocellular carcinoma: a population-based studyYusheng Guo, Hebing Chen, Jiayu Wan, et al.
Cancers|January 28, 2026
Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort StudyZizhuo Wang, Wei Xu, Songlin Song, et al.
BMC Cancer|March 15, 2022
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinomaYusheng Guo, Yanqiao Ren, Lei Chen, et al.
Frontiers in Oncology|December 13, 2021
Early Assessment of Response to Radiofrequency Ablation With CT Perfusion Imaging in Rabbit VX2 Liver Tumor ModelXiaofei Yue, Xiangjun Dong, Mengting Huang, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Technology in Cancer Research & Treatment|October 19, 2022
Addition of Camrelizumab to Transarterial Chemoembolization in Hepatocellular Carcinoma With Untreatable ProgressionYanqiao Ren, Ziyi Liu, Joyman Makamure, et al.
Journal of Oncology|November 29, 2021
The Efficacy of Radiotherapy in the Treatment of Hepatocellular Carcinoma with Distant Organ MetastasisLei Chen, Zhiwen Wang, Songlin Song, et al.
Frontiers in Oncology|June 3, 2022
The Efficacy and Safety of Transarterial Chemoembolization Plus Iodine 125 Seed Implantation in the Treatment of Hepatocellular Carcinoma With Oligometastases: A Case Series ReportsWeihua Zhang, Linxia Wu, Lei Chen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 6, 2019
Endovascular management of transplant renal artery stenosis: A single-center retrospective studyYanqiao Ren, Fu Xiong, Xuefeng Kan, et al.
European Journal of Medical Research|July 5, 2023
Association of the pretreatment lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced hepatocellular carcinomaTao Sun, Yusheng Guo, Bo Sun, et al.
BMC Gastroenterology|July 1, 2020
Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinomaLei Chen, Xuefeng Kan, Tao Sun, et al.
Scientific Reports|January 10, 2024
Ablation alone is noninferior to radiotherapy plus ablation in the patients with early-stage hepatocellular carcinoma: a population-based studyYusheng Guo, Hebing Chen, Jiayu Wan, et al.
Cancers|January 28, 2026
Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort StudyZizhuo Wang, Wei Xu, Songlin Song, et al.
BMC Cancer|March 15, 2022
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinomaYusheng Guo, Yanqiao Ren, Lei Chen, et al.
Frontiers in Oncology|December 13, 2021
Early Assessment of Response to Radiofrequency Ablation With CT Perfusion Imaging in Rabbit VX2 Liver Tumor ModelXiaofei Yue, Xiangjun Dong, Mengting Huang, et al.
Pageof 7